Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Avelumab Plus 5-FU Based Chemotherapy as Adjuvant Treatment for Stage 3 MSI-High or POLE Mutant Colon Cancer (POLEM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03827044
Recruitment Status : Active, not recruiting
First Posted : February 1, 2019
Last Update Posted : March 12, 2021
Sponsor:
Collaborators:
University of Surrey
University of Oxford
Merck KGaA, Darmstadt, Germany
Information provided by (Responsible Party):
Royal Marsden NHS Foundation Trust